Andrew Ishizuka, D.Phil., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malaria Vaccines | 6 | 2019 | 158 | 1.080 |
Why?
|
| Malaria, Falciparum | 6 | 2018 | 1075 | 0.710 |
Why?
|
| Antibodies, Protozoan | 4 | 2017 | 253 | 0.700 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2023 | 4477 | 0.590 |
Why?
|
| Plasmodium falciparum | 6 | 2018 | 1730 | 0.540 |
Why?
|
| Parasitemia | 1 | 2016 | 173 | 0.530 |
Why?
|
| Sporozoites | 5 | 2018 | 82 | 0.410 |
Why?
|
| Adjuvants, Immunologic | 5 | 2023 | 999 | 0.400 |
Why?
|
| Cancer Vaccines | 3 | 2022 | 1023 | 0.340 |
Why?
|
| Vaccines, Attenuated | 3 | 2019 | 342 | 0.300 |
Why?
|
| Antigens, Neoplasm | 3 | 2022 | 1988 | 0.240 |
Why?
|
| Vaccination | 6 | 2023 | 3275 | 0.240 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2020 | 89 | 0.200 |
Why?
|
| Plasmodium yoelii | 2 | 2018 | 39 | 0.200 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2020 | 171 | 0.190 |
Why?
|
| Protozoan Proteins | 2 | 2017 | 825 | 0.190 |
Why?
|
| Liver | 1 | 2016 | 7479 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2020 | 147 | 0.180 |
Why?
|
| Bystander Effect | 1 | 2019 | 81 | 0.170 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2018 | 62 | 0.160 |
Why?
|
| RNA, Protozoan | 1 | 2018 | 43 | 0.160 |
Why?
|
| Therapies, Investigational | 1 | 2019 | 112 | 0.160 |
Why?
|
| Micelles | 1 | 2019 | 203 | 0.160 |
Why?
|
| Melanoma, Experimental | 1 | 2020 | 560 | 0.140 |
Why?
|
| Vaccines, Virus-Like Particle | 1 | 2016 | 40 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2024 | 2540 | 0.120 |
Why?
|
| Herpesvirus 1, Human | 1 | 2019 | 743 | 0.120 |
Why?
|
| Oncolytic Virotherapy | 1 | 2019 | 498 | 0.120 |
Why?
|
| Antigens | 1 | 2019 | 1466 | 0.110 |
Why?
|
| Macaca mulatta | 2 | 2018 | 2375 | 0.110 |
Why?
|
| Capsid Proteins | 1 | 2016 | 479 | 0.110 |
Why?
|
| Nanoparticles | 2 | 2020 | 1898 | 0.100 |
Why?
|
| Toll-Like Receptors | 1 | 2015 | 593 | 0.100 |
Why?
|
| Antigens, Viral | 1 | 2016 | 1035 | 0.100 |
Why?
|
| Interferon-gamma | 2 | 2019 | 3205 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3583 | 0.090 |
Why?
|
| Immunization | 3 | 2019 | 1255 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3874 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 1978 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5524 | 0.080 |
Why?
|
| Vaccines | 1 | 2015 | 823 | 0.070 |
Why?
|
| T-Lymphocytes | 4 | 2017 | 10179 | 0.070 |
Why?
|
| Genetic Vectors | 3 | 2023 | 3421 | 0.070 |
Why?
|
| Mice | 10 | 2024 | 81154 | 0.070 |
Why?
|
| Adaptive Immunity | 2 | 2023 | 715 | 0.070 |
Why?
|
| Melanoma | 1 | 2024 | 5508 | 0.070 |
Why?
|
| Animals | 11 | 2024 | 168660 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 5170 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 4561 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2017 | 5021 | 0.060 |
Why?
|
| Peptides | 1 | 2016 | 4406 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 21824 | 0.060 |
Why?
|
| Immunologic Memory | 2 | 2019 | 1347 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2024 | 880 | 0.040 |
Why?
|
| Brefeldin A | 1 | 2019 | 72 | 0.040 |
Why?
|
| Young Adult | 4 | 2018 | 56392 | 0.040 |
Why?
|
| Vaccines, Conjugate | 1 | 2020 | 333 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2019 | 8856 | 0.040 |
Why?
|
| Hydrodynamics | 1 | 2019 | 158 | 0.040 |
Why?
|
| Human Experimentation | 1 | 2018 | 127 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 545 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2017 | 349 | 0.030 |
Why?
|
| Chloroquine | 1 | 2017 | 279 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2022 | 4437 | 0.030 |
Why?
|
| Oncolytic Viruses | 1 | 2019 | 327 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2020 | 1283 | 0.030 |
Why?
|
| Vaccines, DNA | 1 | 2016 | 305 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 16674 | 0.030 |
Why?
|
| Adult | 6 | 2019 | 213889 | 0.030 |
Why?
|
| Female | 9 | 2020 | 380020 | 0.030 |
Why?
|
| Adolescent | 3 | 2017 | 85729 | 0.030 |
Why?
|
| Cytokines | 2 | 2019 | 7324 | 0.030 |
Why?
|
| Antigens, Protozoan | 1 | 2016 | 322 | 0.030 |
Why?
|
| Tanzania | 1 | 2018 | 1346 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2018 | 12020 | 0.030 |
Why?
|
| Capsid | 1 | 2016 | 437 | 0.030 |
Why?
|
| Spleen | 1 | 2019 | 2359 | 0.030 |
Why?
|
| Bacteriophages | 1 | 2016 | 356 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 1836 | 0.030 |
Why?
|
| Humans | 11 | 2023 | 743811 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2015 | 690 | 0.020 |
Why?
|
| Epitopes | 1 | 2017 | 2570 | 0.020 |
Why?
|
| Middle Aged | 4 | 2017 | 213241 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2720 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 6380 | 0.020 |
Why?
|
| Malaria | 1 | 2019 | 1239 | 0.020 |
Why?
|
| Male | 5 | 2018 | 349776 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2020 | 2961 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9377 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 15993 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2016 | 4216 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2019 | 19232 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16361 | 0.010 |
Why?
|
| Mutation | 1 | 2024 | 29777 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2019 | 23398 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40038 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63042 | 0.010 |
Why?
|
| Child | 1 | 2019 | 77637 | 0.010 |
Why?
|